FDA Import Refusal AEK-8227131-1/11/1 — Amgen Canada Inc
The FDA refused shipment AEK-8227131-1/11/1 from Amgen Canada Inc (Canada) on Feb 27, 2025. The refused product falls under Drugs and Biologics — METHOTREXATE (ANTI-NEOPLASTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 27, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62IDY31 METHOTREXATE (ANTI-NEOPLASTIC)
- Charges
- 75